Mainstream

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Post ContentmdtRead More

You might also be interested in reading Tokenization Is the Way to Realize the Biden’s Electric Vehicle Overhaul.

August 19, 2025
In Mainstream